Profile photo Bart de Keizer

Bart de Keizer

Associate Professor - medical

Strategic program(s):

Biography

Bart de Keizer is a highly skilled radiologist and nuclear medicine physician  affiliated with UMC Utrecht and the Princess Máxima Center for Pediatric Oncology in Utrecht, the Netherlands. He completed his medical degree at UMC Utrecht in 2002, followed by a PhD in Nuclear Medicine in 2004. Dr. de Keizer holds board certifications in both nuclear medicine (2006) and radiology (2015). With over two decades of experience, he plays a pivotal role in imaging departments, combining expertise in both adult and pediatric oncology care. Dr. de Keizer continues to contribute to advancements in medical imaging and treatment. a distinguished researcher in oncology with a specialization in nuclear therapy and diagnostic imaging. His expertise spans a range of cancers, including thyroid cancer, head and neck cancer, and pediatric oncology. 

Research and Publications

Dr. de Keizer's research is dedicated to advancing the diagnostics of oncological diseases. By evaluating current diagnostic scans and introducing new imaging techniques, his work aims to enable image-guided treatments that could increase the cure rates for cancer patients.

In recent years, Dr. de Keizer has been instrumental in the introduction of several new radioactive tracers and PET scans. Notable examples include:

  • Fluor-18-choline PET-CT for detecting parathyroid adenomas
  • Gallium-68-tilmanocept PET-CT for sentinel lymph node detection
  • Fluor-18-MFBG for detecting neuroblastoma
 
 
 

 

 

Associate Professor lecture

Nieuwe scantechnieken voor beeldgestuurde interventies": https://www.youtube.com/watch?v=97FmYAa8LuE

Strategic program(s):

Contact

Research groups

Decision support systems for precision care in translational cancer-imaging

Research aim

To develop, validate and implement decision support systems based on imaging for the diagnosis, prognosis and triaging of oncology patients

Go to group

Recent publications

Assessment of the risk of malignancy in Bethesda III thyroid nodules Karthik Nagaraja Rao, Gregory W. Randolph, Fernando Lopez, Mark Zafereo, Andrés Coca-Pelaz, Cesare Piazza, Prajwal Dange, Juan Pablo Rodrigo, Göran Stenman, Bart de Keizer, Iain Nixon, Shriyash Sinha, Sophie Leboulleux, Antti A. Mäkitie, Abbas Agaimy, Lester Thompson, Alfio Ferlito
Endocrine, 2024, vol. 85, p.473–492
Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial Julia Chisholm, Henry Mandeville, Madeleine Adams, Veronique Minard-Collin, Timothy Rogers, Anna Kelsey, Janet Shipley, Rick R. van Rijn, Isabelle de Vries, Roelof van Ewijk, Bart de Keizer, Susanne A. Gatz, Michela Casanova, Lisa Lyngsie Hjalgrim, Charlotte Firth, Keith Wheatley, Pamela Kearns, Wenyu Liu, Amanda Kirkham, Helen Rees, Gianni Bisogno, Ajla Wasti, Sara Wakeling, Delphine Heenen, Deborah A. Tweddle, Johannes H.M. Merks, Meriel Jenney
Cancers, 2024, vol. 16
A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma Atia Samim, Gitta Bleeker, Kathelijne C.J.M. Kraal, Max M. van Noesel, Bart de Keizer, Godelieve A.M. Tytgat
EJC Paediatric Oncology, 2024, vol. 3
Advances in the Development of Positron Emission Tomography Tracers for Improved Detection of Differentiated Thyroid Cancer Hannelore Iris Coerts, Bart de Keizer, Frederik Anton Verburg
Cancers, 2024, vol. 16
The Additional Value of Somatostatin Receptor Positron Emission Computed Tomography ([68Ga]Ga-DOTATOC PET/CT) Compared with Magnetic Resonance Imaging of the Head and Neck Region in Paraganglioma Patients Carolijn J.M. de Bresser, Bart Jeroen Petri, Arthur J.A.T. Braat, Bart de Keizer, Mark J.C. van Treijen, Jan Willem Dankbaar, Frank A. Pameijer, Marius G.J. Kok, Mischa de Ridder, Bernadette P.M. van Nesselrooij, Remco de Bree, Gert J. de Borst, Johannes A. Rijken
Cancers, 2024, vol. 16, p.1-9
Feasibility of an MR-based digital specimen for tongue cancer resection specimens Klijs Jacob de Koning, Jan Willem Dankbaar, Bart de Keizer, Koen Willemsen, Annette van der Toorn, Gerben Eise Breimer, Robert Jelle Johan van Es, Remco de Bree, Rob Noorlag, Marielle Emile Petronella Philippens
Frontiers in oncology, 2024, vol. 14